Equity, access, and carbon cost-effectiveness of bilateral cataract surgery.
Darren SJ
Ting
;
John C
Buchan
;
(2024)
Equity, access, and carbon cost-effectiveness of bilateral cataract surgery.
Lancet (London, England), 403 (10424).
pp. 353-354.
ISSN 0140-6736
DOI: 10.1016/S0140-6736(23)01923-2
;
(2024)
Equity, access, and carbon cost-effectiveness of bilateral cataract surgery.
Lancet (London, England), 403 (10424).
pp. 353-354.
ISSN 0140-6736
DOI: 10.1016/S0140-6736(23)01923-2
Cataract surgery is one of the most widely done surgeries worldwide. The growing and ageing global population is expected to cause a rising mismatch between available resources and demand for cataract surgery, placing increasing burden on health-care systems, society, and the environment. The 2023 BICAT-NL study2 is a timely and invaluable addition to the literature that supports the effectiveness, safety, and superior cost-effectiveness of immediate sequential bilateral cataract surgery (ISBCS) compared with the conventional model of delayed sequential bilateral cataract surgery (DSBCS).
-
picture_as_pdf - Ting-Buchan-2024-Equity-Access-and-Carbon-Cost-Effectiveness-letter-to-Lancet.pdf
-
subject - Accepted Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads